- Scheme Category:
- Equity Scheme >
- Sectoral/Thematic Funds
NAV: ₹ 33.5550 ↓ -1.3%
[as on 23 January, 2026]
NAV chart
SMA (Simple Moving Average)
Returns
| Name | YTD | 1D | 1W | 1M | 3M | 1Y | 3Y | 5Y | 7Y | 10Y |
|---|
| Tata India Pharma & Healthcare Fund-Direct Plan-Growth | -5.01% | -1.3% | -3.65% | -5.43% | -7.62% | -3.64% | 21.49% | 15.6% | 20.16% | 13.15% |
Portfolio
Asset allocation
| Equity | Debt | Realestate | Commodities | Cash & Equivalents |
|---|
| 98.47% |
0.00% (Arbitrage: 0.00%) |
0.00% |
0.00% |
1.53% |
Equity
| Name | Symbol / ISIN | Sector | Weight % |
|---|
| SUN PHARMACEUTICAL INDUSTRIES LTD | SUNPHARMA (INE044A01036) | Pharmaceuticals & Biotechnology | 9.59% |
| APOLLO HOSPITALS ENTERPRISE LTD | APOLLOHOSP (INE437A01024) | Healthcare Services | 5.13% |
| HEALTHCARE GLOBAL ENTERPRISES LTD | HCG (INE075I01017) | Healthcare Services | 4.96% |
| LUPIN LTD | LUPIN (INE326A01037) | Pharmaceuticals & Biotechnology | 4.90% |
| MAX HEALTHCARE INSTITUTE LTD | MAXHEALTH (INE027H01010) | Healthcare Services | 4.71% |
| TORRENT PHARMACEUTICALS LTD | TORNTPHARM (INE685A01028) | Pharmaceuticals & Biotechnology | 4.52% |
| ALKEM LABORATORIES LTD | ALKEM (INE540L01014) | Pharmaceuticals & Biotechnology | 4.42% |
| ABBOTT INDIA LTD | ABBOTINDIA (INE358A01014) | Pharmaceuticals & Biotechnology | 4.02% |
| CIPLA LTD | CIPLA (INE059A01026) | Pharmaceuticals & Biotechnology | 3.92% |
| IPCA LABORATORIES LTD | IPCALAB (INE571A01038) | Pharmaceuticals & Biotechnology | 3.56% |
| AJANTA PHARMA LTD | AJANTPHARM (INE031B01049) | Pharmaceuticals & Biotechnology | 3.35% |
| RAINBOW CHILDRENS MEDICARE LTD | RAINBOW (INE961O01016) | Healthcare Services | 3.30% |
| ASTER DM HEALTHCARE LTD | ASTERDM (INE914M01019) | Healthcare Services | 3.29% |
| DIVI LABORATORIES LTD | DIVISLAB (INE361B01024) | Pharmaceuticals & Biotechnology | 3.26% |
| J.B.CHEMICALS & PHARMACEUTICALS LTD | JBCHEPHARM (INE572A01036) | Pharmaceuticals & Biotechnology | 3.22% |
| METROPOLIS HEALTHCARE LTD | METROPOLIS (INE112L01020) | Healthcare Services | 3.18% |
| FDC LTD | FDC (INE258B01022) | Pharmaceuticals & Biotechnology | 2.93% |
| DR. LAL PATH LABS LTD | LALPATHLAB (INE600L01024) | Healthcare Services | 2.89% |
| MANKIND PHARMA LTD | MANKIND (INE634S01028) | Pharmaceuticals & Biotechnology | 2.63% |
| DR. AGARWALS HEALTH CARE LTD | AGARWALEYE (INE943P01029) | Healthcare Services | 2.33% |
| GLENMARK PHARMACEUTICALS LTD | GLENMARK (INE935A01035) | Pharmaceuticals & Biotechnology | 2.17% |
| PI INDUSTRIES LTD | PIIND (INE603J01030) | Fertilizers & Agrochemicals | 2.17% |
| SAI LIFE SCIENCES LTD | SAILIFE (INE570L01029) | Pharmaceuticals & Biotechnology | 2.09% |
| KRISHNA INSTITUTE OF MEDICAL SCIENCES LTD | KIMS (INE967H01025) | Healthcare Services | 2.01% |
| SYNGENE INTERNATIONAL LTD | SYNGENE (INE398R01022) | Healthcare Services | 1.76% |
| DR REDDYS LABORATORIES LTD | DRREDDY (INE089A01031) | Pharmaceuticals & Biotechnology | 1.63% |
| COHANCE LIFESCIENCES LTD | COHANCE (INE03QK01018) | Pharmaceuticals & Biotechnology | 1.51% |
| VIJAYA DIAGNOSTIC CENTRE LTD | VIJAYA (INE043W01024) | Healthcare Services | 1.50% |
| WOCKHARDT LTD | WOCKPHARMA (INE049B01025) | Pharmaceuticals & Biotechnology | 1.41% |
| AKUMS DRUGS AND PHARMACEUTICALS LTD | AKUMS (INE09XN01023) | Pharmaceuticals & Biotechnology | 0.89% |
| HIKAL LTD | HIKAL (INE475B01022) | Pharmaceuticals & Biotechnology | 0.71% |
| PFIZER LTD | PFIZER (INE182A01018) | Pharmaceuticals & Biotechnology | 0.42% |
| JUBILANT PHARMOVA LTD | JUBLPHARMA (INE700A01033) | Pharmaceuticals & Biotechnology | 0.06% |
| LAXMI DENTAL LTD | LAXMIDENTL (INE0WO601020) | Healthcare Equipment & Supplies | 0.03% |
Portfolio data is as on date 31 October, 2025
NAV (Net asset value) history
Tata India Pharma & Healthcare Fund-Direct Plan-Growth - 30 days NAV history
| Date | NAV |
|---|
| 23 January, 2026 | 33.5550 |
| 22 January, 2026 | 33.9979 |
| 21 January, 2026 | 33.8561 |
| 20 January, 2026 | 33.9913 |
| 19 January, 2026 | 34.6074 |
| 16 January, 2026 | 34.8246 |
| 14 January, 2026 | 35.0919 |
| 13 January, 2026 | 35.2102 |
| 12 January, 2026 | 35.1281 |
| 9 January, 2026 | 35.3109 |
| 8 January, 2026 | 35.6470 |
| 7 January, 2026 | 36.0780 |
| 6 January, 2026 | 35.9577 |
| 5 January, 2026 | 35.6612 |
| 2 January, 2026 | 35.5663 |
| 1 January, 2026 | 35.3245 |
| 31 December, 2025 | 35.3723 |
| 30 December, 2025 | 35.0154 |
| 29 December, 2025 | 35.2605 |
| 26 December, 2025 | 35.4274 |
| 24 December, 2025 | 35.4662 |
| 23 December, 2025 | 35.4818 |
| 22 December, 2025 | 35.5409 |
| 19 December, 2025 | 35.3410 |
| 18 December, 2025 | 35.0293 |
| 17 December, 2025 | 35.0980 |
| 16 December, 2025 | 35.3994 |
| 15 December, 2025 | 35.6160 |
| 12 December, 2025 | 35.6089 |
| 11 December, 2025 | 35.5863 |
FAQ (Frequently asked questions)
What is latest/current NAV/price of Tata India Pharma & Healthcare Fund-Direct Plan-Growth?
The latest NAV of Tata India Pharma & Healthcare Fund-Direct Plan-Growth is 33.5550 as on 23 January, 2026.
What are YTD (year to date) returns of Tata India Pharma & Healthcare Fund-Direct Plan-Growth?
The YTD (year to date) returns of Tata India Pharma & Healthcare Fund-Direct Plan-Growth are -5.01% as on 23 January, 2026.
What are 1 year returns of Tata India Pharma & Healthcare Fund-Direct Plan-Growth?
The 1 year returns of Tata India Pharma & Healthcare Fund-Direct Plan-Growth are -3.64% as on 23 January, 2026.
What are 3 year CAGR returns of Tata India Pharma & Healthcare Fund-Direct Plan-Growth?
The 3 year annualized returns (CAGR) of Tata India Pharma & Healthcare Fund-Direct Plan-Growth are 21.49% as on 23 January, 2026.
What are 5 year CAGR returns of Tata India Pharma & Healthcare Fund-Direct Plan-Growth?
The 5 year annualized returns (CAGR) of Tata India Pharma & Healthcare Fund-Direct Plan-Growth are 15.6% as on 23 January, 2026.
What are 10 year CAGR returns of Tata India Pharma & Healthcare Fund-Direct Plan-Growth?
The 10 year annualized returns (CAGR) of Tata India Pharma & Healthcare Fund-Direct Plan-Growth are 15.6% as on 23 January, 2026.